Since Jason Momoa revealed his new girlfriend to the world on Instagram on Monday, the pair has been the talk of the internet.
Though some may be surprised, he has been making subtle references to their long-simmering romance to followers for some time.
When he was still married to Lisa Bonet, the 44-year-old actor got to know the 32-year-old actress on the set of the 2021 Netflix movie Sweet Girl. But there’s a catch!
Momoa and his husband separated for more than five years, although they were still legally wed.
Bonet and Momoa formally separated on October 7, 2020, therefore there was no conflict between them when he and Arjona started dating.
On January 8 of this year, Bonet filed for divorce, and the next day, their cases were settled amicably.
Momoa went all out, creating a carousel of pictures from their most recent trip to Japan, now that he could finally show them all how much he loved them.
He referred to Arjona as “mi amor” in the letter, but if you’re not sure what that means, just look at their adorable pictures of one another.
Their close embrace is depicted through their body language in the second picture, where her hand is softly resting on his arm and his arms are wrapped around her. It’s not laughing!
The writer said, “Japan, you are a dream come true; you blew my mind.” We sincerely thank everyone who opened their homes to us so that we could embark on yet another amazing journey with our beloved and make memories with both old and new friends. Motorbikes and mayhem on the highway. Warm regards, J.
In 2019, Arjona wed attorney Edgardo Canales; however, little is known about their separation or if a divorce was requested.
Despite the impression that Arjona is a relatively new member of the Momoa family, his stepdaughter Zoë Kravitz chose her to be the director of Blink Twice, which will be released in theaters on August 23 and stars Channing Tatum.
Given that Kravitz and Tatum are now engaged, the wedding is probably going to be spectacular, and Momoa, Bonet, and Lenny Kravitz will probably be there.
Following 13 years of dating, Bonet and Momoa made the decision to tie the knot in October 2017.
The 15-year-old boy Nakoa-Wolf and the 16-year-old daughter Lola are being reared by the ex-couple behind closed doors.
They didn’t declare their split on Instagram until January 2022, writing, “We’ve all felt the strain and adjustments of these revolutionary times. “A revolution is taking place, and our family is not an exception… feeling and growing from the seismic shifts occurring,” said the joint statement.As a result, we inform our families of our impending divorce. We share this not because we think it’s important to draw attention to ourselves, but rather so that we can live morally and authentically in our day-to-day lives.
Meet Twins with the Rare Benjamin Button Syndrome, Who Became Symbols of Resilience
In a small Brazilian town, there resides an extraordinary duo of identical twins named Elis and Eloá. Their story serves as a beacon of resilience and the remarkable power of the human spirit. Afflicted with Hutchinson-Gilford Progeria Syndrome, a rare and fatal genetic disorder causing accelerated aging, these twins confront their adversities with remarkable grace and strength, earning admiration from people worldwide.
Understanding Hutchinson-Gilford Progeria syndrome
HGPS stands as an exceptionally rare disorder, impacting roughly 1 in 20 million newborns globally. Marked by rapid aging from early childhood, individuals with progeria often display growth delays, diminished body fat and hair, prematurely aged skin, joint stiffness, and severe cardiovascular issues. Typically, those with HGPS have an average life expectancy of about 14.5 years, though some may extend into their late teens or early twenties. This syndrome gained public attention through the film The Curious Case of Benjamin Button.
The condition is caused by a mutation in the LMNA gene, which produces the lamin A protein responsible for maintaining the structural integrity of the cell nucleus. The mutation results in the production of an abnormal version of the protein, called progerin, which causes cells to become unstable and die prematurely.
Elis and Eloá’s journey
Elis and Eloá swiftly captured attention because of their distinctive medical condition. Despite the physical hurdles imposed by progeria, their contagious smiles and steadfast optimism have emerged as beacons of hope and inspiration. Guilherme and Elismar, the twins’ parents, have dedicated their lives to offering the utmost care for their daughters, striving to ensure they experience as normal a life as feasible within the confines of their condition.
The family’s path has been far from easy. Their daily life is filled with demanding medical routines, including physiotherapy, aimed at addressing joint stiffness and preserving mobility. Despite these challenges, Elis and Eloá approach each day with remarkable bravery and an unparalleled enthusiasm for life, which is truly remarkable.
A global community of support
Elis and Eloá’s narrative has touched hearts worldwide, sparking a surge of solidarity from individuals and groups committed to promoting awareness about progeria and backing research endeavors. The Progeria Research Foundation, a pivotal entity in this realm, has played a vital role in propelling research forward and furnishing assistance to families grappling with the condition.
Through social media platforms, the twins’ journey is shared with a broad audience, fostering a sense of community and solidarity. Their family’s updates, documenting both the highs and lows of their daily lives, provide invaluable insights into the realities of living with progeria, while also spreading a message of hope and perseverance.
Advances in research and hope for the future
In recent years, there have been remarkable advancements in comprehending and addressing progeria. A notable milestone occurred in 2020 when the U.S. Food and Drug Administration (FDA) granted approval for the first progeria treatment: lonafarnib. This medication has demonstrated efficacy in prolonging the lives of children with progeria by mitigating the accumulation of progerin in cells, thereby decelerating the disease’s advancement.
Though a cure remains elusive, ongoing research presents promising prospects. Scientists are delving into gene-editing methodologies, like CRISPR, as potential means to rectify the genetic mutation at its root. For families such as Elis and Eloá’s, these breakthroughs offer a ray of hope for the future.
And in our other article, we recounted the remarkable story of a girl born without a nose, affectionately dubbed “Voldemort,” who refuses to let her differences define her.
Leave a Reply